APOE and Alzheimer disease: Late-onset AD also is associated with the metabolic pathway of the ε4 allele of the apolipoprotein E (APOE-ε4) gene with the risk for developing AD becoming more than 20 times greater in individuals harboring two APOE-ε4 alleles [5,10–12].